• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Investigation Report on China Quetiapine Market, 2009-2018 Product Image

Investigation Report on China Quetiapine Market, 2009-2018

  • ID: 2769125
  • February 2014
  • Region: China
  • 40 Pages
  • China Research & Intelligence

Schizophrenia is a common mental disorder. As a chronic disease, schizophrenia can lead to recurrent or persistent symptoms in most patients' whole life. As Chinese economy and society develops, life and work here has become increasingly stressful. As a result, recurrence rate of schizophrenia has also increased. Statistics shows that the number of schizophrene in China has exceeded 10 million by the end of 2013, and it is still rising year after year.

Quetiapine is originally developed by Astra Zeneca and has curative effect on various schizophrenic symptoms. It was firstly approved to the U.K. market in July 1997 and to the U.S. market on September 26, 1997 by FDA with the trade name ""Seroquel"". Patent of this product expired on March 26, 2012. To prolong its life cycle, long-acting release formulation of quetiapine developed by Astra Zeneca was approved to the U.S. market on May 17, 2007 with the trade name ""Seroquel XR"", which extends its patent protection to November 28, 2017. After that it has come into markets of several countries sequentially, such as Germany and China.

In 2012, global sales revenue of Seroquel and Seroquel XR was USD 2,803 million, of which READ MORE >

Note: Product cover images may vary from those shown

1 Relevant Concepts of Quetiapine
1.1 Indication
1.2 Sales Status on the Global Market

2 Market Overview of Quetiapine in China
2.1 Patent Status
2.2 Production Status of Generic Drug
2.3 Major Manufacturers
2.4 Market Size

3 Investigation on Sales Value of Quetiapine in China, 2009-2013
3.1 Total Sales Value
3.2 Sales Value by Region

4 Investigation on Market Share of Major Quetiapine Manufacturers in China, 2009-2013
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Investigation on Market Size of Quetiapine by Dosage Form in China, 2009-2013
5.1 Market Share by Sales Value and Dosage Form
5.2 Market Share by Sales Volume and Dosage Form

6 Reference Price of Quetiapine Produced by Different Enterprises in China Hospital Market, 2014
6.1 Hunan Dongting Pharmaceutical Co., Ltd.
6.2 Suzhou Pharmaceutical Group Co., Ltd.
6.3 AstraZeneca

7 Analysis on Major Quetiapine Manufacturers in China, 2009-2014
7.1 Hunan Dongting Pharmaceutical Co., Ltd.
7.2 Suzhou Pharmaceutical Group Co., Ltd.
7.3 AstraZeneca

8 Prospect of China Quetiapine Market, 2014-2018
8.1 Prediction of Schizophrenia Incidence in China
8.2 Research Status of Generic Drug
8.3 Forecast on Market Size
8.4 Forecast on Market Competition

Selected Charts

Chart Quetiapine Products Approved to Market in China by 2014
Chart Sales Value of Quetiapine in Global Market, 2009-2013
Chart Sales Value of Quetiapine in China Sample Hospital Market, 2009-2013
Chart Sales Value of Quetiapine by Region in China, 2009-2013
Chart Market Share of Quetiapine Enterprises by Sales Volume in China, 2009-2013
Chart Price of Quetiapine Produced by MSD (UK) in China Hospital Market, 2013
Chart Price of Quetiapine Produced by Sichuan Xicheng Otsuka Pharmaceutical Co., Ltd. in China Hospital Market, 2013
Chart Forecast on Market Size of Hospital-use Quetiapine in China, 2014-2018
Chart Sales Value of Singulair in Global Market, 2008-2013

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

ALSO AVAILABLE IN THE FOLLOWING LANGUAGES

RELATED PRODUCTS

Our Clients

Our clients' logos